Ritter Pharmaceuticals (RTTR) Reports Q2 Loss of $0.48/Share

August 8, 2016 8:36 AM EDT
Get Alerts RTTR Hot Sheet
Trade RTTR Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Ritter Pharmaceuticals (NASDAQ: RTTR) reported Q2 EPS of ($0.48), versus ($4.18) reported last year.

For earnings history and earnings-related data on Ritter Pharmaceuticals (RTTR) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment